SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019835
Filing Date
2023-05-09
Accepted
2023-05-09 17:05:33
Documents
85
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q inva-20230331.htm   iXBRL 10-Q 3374400
2 EX-10.1 inva-ex10_1.htm EX-10 95807
3 EX-31.1 inva-ex31_1.htm EX-31 16171
4 EX-31.2 inva-ex31_2.htm EX-31 16174
5 EX-32 inva-ex32.htm EX-32 26897
  Complete submission text file 0000950170-23-019835.txt   15211996

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20230331_cal.xml EX-101.CAL 93811
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20230331_pre.xml EX-101.PRE 618599
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inva-20230331_lab.xml EX-101.LAB 729832
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20230331.xsd EX-101.SCH 97492
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20230331_def.xml EX-101.DEF 479393
79 EXTRACTED XBRL INSTANCE DOCUMENT inva-20230331_htm.xml XML 3307488
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 23903209
SIC: 2834 Pharmaceutical Preparations